结合信号检测与生物学合理性识别自发报告中的药物相互作用
该研究提出一种贝叶斯框架,用于在自发报告中区分单药与药物组合信号以识别药物相互作用(DDI),并耦合系统药理学方法自动评估生物学合理性。整合统计与生物学证据后,药物-靶点-不良事件关联的AUC从0.620提升至0.722(16.5%),药物酶信息从0.580提升至0.673(16.0%),药物转运体信息从0.568提升至0.653(15.0%)。在FAERS中检测QT延长和横纹肌溶解的潜在DDI信号,强调系统药理学可增强药物警戒中的统计信号检测。
要点
- 贝叶斯框架可区分单药与药物组合信号以识别DDI。
- 整合系统药理学证据使AUC提升15.0%–16.5%。
- 在FAERS中检测QT延长和横纹肌溶解的潜在DDI信号。
核心结论
- 整合统计信号与系统药理学生物学合理性评估,可提升上市后DDI监测中信号检测的性能。
研究设计与样本
- 提出贝叶斯框架用于识别DDI信号并区分单药与药物组合信号,耦合系统药理学方法自动评估生物学合理性。
- 在FDA不良事件报告系统(FAERS)中应用该方法检测QT延长和横纹肌溶解的潜在DDI信号。
主要发现
- 整合药物-靶点-不良事件关联信息后,AUC从0.620提升至0.722,改善16.5%。
- 整合药物酶信息后,AUC从0.580提升至0.673,改善16.0%。
- 整合药物转运体信息后,AUC从0.568提升至0.653,改善15.0%。
临床怎么用
- 在药物警戒DDI监测中,可将统计信号检测与系统药理学生物学合理性评估结合使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Translational approaches can benefit post-marketing drug safety surveillance through the growing availability of systems pharmacology data. Here, we propose a novel Bayesian framework for identifying drug-drug interaction (DDI) signals and differentiating between individual drug and drug combination signals. This framework is coupled with a systems pharmacology approach for automated biological plausibility assessment. Integrating statistical and biological evidence, our method achieves a 16.5% improvement (AUC: from 0.620 to 0.722) with drug-target-adverse event associations, 16.0% (AUC: from 0.580 to 0.673) with drug enzyme, and 15.0% (AUC: from 0.568 to 0.653) with drug transporter information. Applying this approach to detect potential DDI signals of QT prolongation and rhabdomyolysis within the FDA Adverse Event Reporting System (FAERS), we emphasize the significance of systems pharmacology in enhancing statistical signal detection in pharmacovigilance. Our study showcases the promise of data-driven biological plausibility assessment in the context of challenging post-marketing DDI surveillance.
引用
- Kontsioti E, Maskell S, Anderson I, et al. Identifying Drug-Drug Interactions in Spontaneous Reports Utilizing Signal Detection and Biological Plausibility Aspects. Clin Pharmacol Ther. 2024. PMID: 38590106. doi:10.1002/cpt.3258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。